These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 35432628)
1. Prognostic and Functional Analysis of Mei S; Li Y; Kang X Dis Markers; 2022; 2022():4143447. PubMed ID: 35432628 [TBL] [Abstract][Full Text] [Related]
2. Identification of differentially expressed genes and functional annotations associated with metastases of the uveal melanoma. Xu Y; Han W; Xu WH; Wang Y; Yang XL; Nie HL; Yao J; Shen GL; Zhang XF J Cell Biochem; 2019 Nov; 120(11):19202-19214. PubMed ID: 31270856 [TBL] [Abstract][Full Text] [Related]
3. Construction of oxidative phosphorylation-related prognostic risk score model in uveal melanoma. Zhan Z; Lin K; Wang T BMC Ophthalmol; 2024 May; 24(1):204. PubMed ID: 38698303 [TBL] [Abstract][Full Text] [Related]
4. Programmed Cell Death-Related Gene Signature Associated with Prognosis and Immune Infiltration and the Roles of HMOX1 in the Proliferation and Apoptosis were Investigated in Uveal Melanoma. Zhao Y; Wang L; Li X; Jiang J; Ma Y; Guo S; Zhou J; Li Y Genes Genomics; 2024 Jul; 46(7):785-801. PubMed ID: 38767825 [TBL] [Abstract][Full Text] [Related]
5. Dysregulation of B7 family and its association with tumor microenvironment in uveal melanoma. Chen Y; Zheng A; Zhang Y; Xiao M; Zhao Y; Wu X; Li M; Du F; Chen Y; Chen M; Li W; Li X; Sun Y; Gu L; Xiao Z; Shen J Front Immunol; 2022; 13():1026076. PubMed ID: 36311731 [TBL] [Abstract][Full Text] [Related]
6. CARD11 is a prognostic biomarker and correlated with immune infiltrates in uveal melanoma. Shi X; Xia S; Chu Y; Yang N; Zheng J; Chen Q; Fen Z; Jiang Y; Fang S; Lin J PLoS One; 2021; 16(8):e0255293. PubMed ID: 34370778 [TBL] [Abstract][Full Text] [Related]
7. Modulating DNA damage response in uveal melanoma through embryonic stem cell microenvironment. Zhang Y; Zheng J; Chen M; Zhao S; Ma R; Chen W; Liu J BMC Cancer; 2024 Apr; 24(1):519. PubMed ID: 38654216 [TBL] [Abstract][Full Text] [Related]
8. Identification of a novel immune-related gene signature for prognosis and the tumor microenvironment in patients with uveal melanoma combining single-cell and bulk sequencing data. Wang W; Zhao H; Wang S Front Immunol; 2023; 14():1099071. PubMed ID: 36793711 [TBL] [Abstract][Full Text] [Related]
9. Multi-omics approaches identify novel prognostic biomarkers of autophagy in uveal melanoma. Jin W; Wu L; Hu L; Fu Y; Fan Z; Mou Y; Ma K J Cancer Res Clin Oncol; 2023 Dec; 149(18):16691-16703. PubMed ID: 37725244 [TBL] [Abstract][Full Text] [Related]
10. Development of a prognostic risk model of uveal melanoma based on N7-methylguanosine-related regulators. Wu P; Zhang Q; Zhong P; Chai L; Luo Q; Jia C Hereditas; 2024 Jul; 161(1):22. PubMed ID: 38987843 [TBL] [Abstract][Full Text] [Related]
11. Single-cell hdWGCNA reveals metastatic protective macrophages and development of deep learning model in uveal melanoma. Sun Y; Wu J; Zhang Q; Wang P; Zhang J; Yuan Y J Transl Med; 2024 Jul; 22(1):695. PubMed ID: 39075441 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of deregulated microRNAs in uveal melanomas. Falzone L; Romano GL; Salemi R; Bucolo C; Tomasello B; Lupo G; Anfuso CD; Spandidos DA; Libra M; Candido S Mol Med Rep; 2019 Apr; 19(4):2599-2610. PubMed ID: 30816460 [TBL] [Abstract][Full Text] [Related]
13. MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma. Wang T; Zhang Y; Bai J; Xue Y; Peng Q BMC Cancer; 2021 Sep; 21(1):1068. PubMed ID: 34587931 [TBL] [Abstract][Full Text] [Related]
14. Identification and validation of a costimulatory molecule-related signature to predict the prognosis for uveal melanoma patients. Zhao M; Yu Y; Song Z Sci Rep; 2024 Apr; 14(1):9146. PubMed ID: 38644411 [TBL] [Abstract][Full Text] [Related]
15. Immune marker signature helps to predict survival in uveal melanoma. Pan LS; Ackbarkha Z; Zeng J; Huang ML; Yang Z; Liang H Math Biosci Eng; 2021 May; 18(4):4055-4070. PubMed ID: 34198425 [TBL] [Abstract][Full Text] [Related]
16. Multi-Platform Omics Analysis for Identification of Molecular Characteristics and Therapeutic Targets of Uveal Melanoma. Kim YJ; Park SJ; Maeng KJ; Lee SC; Lee CS Sci Rep; 2019 Dec; 9(1):19235. PubMed ID: 31848373 [TBL] [Abstract][Full Text] [Related]
17. Cross talk between tumor stemness and microenvironment for prognosis and immunotherapy of uveal melanoma. Wan Q; Ren X; Tang J; Ma K; Deng YP J Cancer Res Clin Oncol; 2023 Oct; 149(13):11951-11968. PubMed ID: 37420017 [TBL] [Abstract][Full Text] [Related]
18. A Novel Glycolysis-Related Signature for Predicting the Prognosis and Immune Infiltration of Uveal Melanoma. Guo X; Yu X; Zhang Y; Luo H; Huang R; Zeng Y; Duan C; Chen C Ophthalmic Res; 2023; 66(1):692-705. PubMed ID: 36858025 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive Analysis of Enhancer RNAs Identifies LINC00689 and ELFN1-AS1 as Novel Prognostic Biomarkers in Uveal Melanoma. Zhao S; Jiang H; Liu J; Li DY; Li B; Long QR; Zheng L; Gu H Dis Markers; 2022; 2022():5994800. PubMed ID: 35251374 [TBL] [Abstract][Full Text] [Related]
20. Validation of an Ultraviolet Light Response Gene Signature for Predicting Prognosis in Patients with Uveal Melanoma. Orozco CA; Mejía-García A; Ramírez M; González J; Castro-Vega L; Kreider RB; Serrano S; Combita AL; Bonilla DA Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]